SARCOMA

Latest News

Peers Weigh Efficacy vs Toxicity of Nirogacestat in Progressive Desmoid Tumors
Peers Weigh Efficacy vs Toxicity of Nirogacestat in Progressive Desmoid Tumors

June 16th 2025

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in progressive desmoid tumors.

EFTISARC-NEO Trial Meets Primary End Point in Soft Tissue Sarcoma
EFTISARC-NEO Trial Meets Primary End Point in Soft Tissue Sarcoma

May 28th 2025

THE001, Novel Sarcoma Treatment, Earns FDA Orphan Drug Designation
THE001, Novel Sarcoma Treatment, Earns FDA Orphan Drug Designation

May 12th 2025

Maintenance Regorafenib in Advanced Soft-Tissue Sarcoma Delays Progression
Maintenance Regorafenib in Advanced Soft-Tissue Sarcoma Delays Progression

April 28th 2025

DeFi Study Establishes Role of Nirogacestat in Desmoid Tumors
DeFi Study Establishes Role of Nirogacestat in Desmoid Tumors

April 21st 2025

Video Series
Video Interviews
Podcasts

More News